|
|
|
|
|
|
|
|
|
|
| Date | News |
| Feb. 20, 2008 | Cadence Pharmaceuticals Completes $49.3 Million Registered Direct Offering
| | Feb. 20, 2008 | Michael L. Eskew Elected to Lilly Board of Directors
| | Feb. 20, 2008 | Wyeth Wins Thimerosal-Autism Case in Maryland Court
| | Feb. 18, 2008 | Abbott Announces 10.8 Percent Increase in Quarterly Dividend
| | Feb. 18, 2008 | Edwards Lifesciences Announces Organizational Changes
| | Feb. 13, 2008 | Baxter Declares Quarterly Dividend
| | Feb. 13, 2008 | Boston Scientific Announces Court Decision
| | Feb. 13, 2008 | Invitrogen Renews, Expands License and Supply Agreement with Luminex
| | Feb. 10, 2008 | Mylan Restores Availability of Generic Levothyroxine in Florida
| | Feb. 6, 2008 | NextGen Bioscience, Inc. Appoints Scientific Advisory Board
| | Feb. 6, 2008 | Wyeth Announces Election of Timothy P. Cost as Senior Vice President, Corporate Affairs
| | Feb. 5, 2008 | Baxter's Costa Rica Facility Recognized With Shingo Prize for Excellence in Manufacturing
|
|
|
